Cargando…
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study
Background and Aims: There is conflicting evidence regarding the association between proton pump inhibitors (PPI) and the risk of acquisition and severity of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Aim: To evaluate the association between PPI exposure and infection and devel...
Autores principales: | Shafrir, Asher, Benson, Ariel A., Katz, Lior H., Hershcovici, Tiberiu, Bitan, Menachem, Paltiel, Ora, Calderon-Margalit, Ronit, Safadi, Rifaat, Shauly-Aharonov, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854493/ https://www.ncbi.nlm.nih.gov/pubmed/35185561 http://dx.doi.org/10.3389/fphar.2022.791074 |
Ejemplares similares
-
Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study
por: Shauly-Aharonov, Michal, et al.
Publicado: (2021) -
The Association between Serum Vitamin D Levels and Helicobacter pylori Presence and Eradication
por: Shafrir, Asher, et al.
Publicado: (2021) -
Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
por: Shafrir, Asher, et al.
Publicado: (2023) -
Patients with low ALT levels are at increased risk for severe COVID-19
por: Genzel, Dor, et al.
Publicado: (2023) -
Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)